Sai Life Sciences Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Sai Life Sciences Ltd is ₹ 1070 as of 30 Apr 15:30 . The P/E Ratio of Sai Life Sciences Ltd changed from 93.4 on March 2025 to 93.4 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 22.6 on March 2021 to 3943 on March 2025 . This represents a CAGR of 180.78% over 5 years The Market Cap of Sai Life Sciences Ltd changed from ₹ 15883 crore on March 2025 to ₹ 15883 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 5009 crore on March 2021 to ₹ 2005 crore on March 2025 . This represents a CAGR of -16.73% over 5 years The revenue of Sai Life Sciences Ltd for the Dec '25 is ₹ 564.84 crore as compare to the Sep '25 revenue of ₹ 552.8 crore. This represent the growth of 2.18% The revenue of Solara Active Pharma Sciences Ltd for the Dec '25 is ₹ 349 crore as compare to the Sep '25 revenue of ₹ 314.03 crore. This represent the growth of 11.14% The ebitda of Sai Life Sciences Ltd for the Dec '25 is ₹ 187.94 crore as compare to the Sep '25 ebitda of ₹ 161.15 crore. This represent the growth of 16.62% The ebitda of Solara Active Pharma Sciences Ltd for the Dec '25 is ₹ 30.59 crore as compare to the Sep '25 ebitda of ₹ 35.22 crore. This represent the decline of -13.15% The net profit of Sai Life Sciences Ltd changed from ₹ -13.5 crore to ₹ 100.38 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -13.46 crore to ₹ -17.43 crore over 7 quarters. This represents a CAGR of 15.92% The Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 11.38 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.

FAQs for the comparison of Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Sai Life Sciences Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Sai Life Sciences Ltd is 22,668 Cr while Market cap of Solara Active Pharma Sciences Ltd is 1,803 Cr

What are the key factors driving the stock performance of Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd?

As of May 3, 2026, the Sai Life Sciences Ltd stock price is INR ₹1070.4. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹498.6.

How do dividend payouts of Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Sai Life Sciences Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.